Our UHN programs and services are among the most advanced in the world. We have grouped our physicians, staff, services and resources into 10 medical programs to meet the needs of our patients and help us make the most of our resources.
University Health Network is a health care and medical research organization in Toronto, Ontario, Canada. The scope of research and complexity of cases at UHN has made us a national and international source for discovery, education and patient care.
Our 10 medical programs are spread across eight hospital sites – Princess Margaret, Toronto General, Toronto Rehab’s five sites, Toronto Western – as well as our education programs through the Michener Institute of Education at UHN. Learn more about the services, programs and amenities offered at each location.
Maps & Directions
Find out how to get to and around our nine locations — floor plans, parking, public transit, accessibility services, and shuttle information.
Ways You Can Help
Being touched by illness affects us in different ways. Many people want to give back to the community and help others. At UHN, we welcome your contribution and offer different ways you can help so you can find one that suits you.
The Newsroom is the source for media looking for information about UHN or trying to connect with one of our experts for an interview. It’s also the place to find UHN media policies and catch up on our news stories, videos, media releases, podcasts and more.
A trio of researchers from Toronto Rehabilitation Institute has received the UHN Inventor of the Year Award for a device which has a very real impact on the daily health and well-being of patients.
Drs. Hisham Alshaer, T. Douglas Bradley and Geoff Fernie were presented the award by UHN's Technology Development & Commercialization Office at Wednesday's Annual General Meeting.
It recognizes outstanding inventiveness coupled with commercialization success over the past year.
The three co-inventors founded BresoTec Inc. around a device called BresoDx, which uses proprietary acoustic and movement recording technology as an aid in the diagnosis of sleep apnea, which affects about 10 per cent of adults globally but is not widely diagnosed, especially outside North America.
If left untreated, sleep apnea can lead to serious health complications, including increased risk of hypertension, stroke and heart failure, and has been linked to a higher risk of traffic accidents due to sleepiness.
BresoDx can be used at home
The low rate of diagnosis is typically due to the high cost and inconvenience of undergoing overnight sleep testing in a laboratory.
But BresoDx is a portable, self-contained and battery-operated device patients can use at home.
Dr. Alshaer, a scientist at Toronto Rehabilitation Institute as well as a physician and biomedical engineer, has through his career developed devices for the diagnosis and treatment of functional voice disorders, the diagnosis of diabetic peripheral neuropathy, and the diagnosis of sleep apnea. He is Chief Scientist with BresoTec.
Dr. Fernie, a biomedical engineer who is the Research Director of Toronto Rehabilitation Institute, where he has led the growth of its research enterprise to become one of the most advanced rehabilitation programs in the world, has focused his work on two primary goals: preventing injury and disease, and helping individuals and their family caregivers continue to live in their own homes as they age. He is CEO of BresoTec.
Dr. Bradley, a Senior Scientist with both Toronto General Research Institute and Toronto Rehabilitation Institute, is the Chief Medical Officer of BresoTec. A respirologist who directs the Sleep Research Laboratories at UHN, he has done extensive research on sleep apnea, including its influence on cardiovascular disease and hypertension.